Clinical Trial Update: Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

Phase III trial comparing rosuvastatin+fenofibrate vs rosuvastatin in mixed dyslipidemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemias

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Mixed Dyslipidemias | Phase 3 | Status: COMPLETED